Michael F. Adams, Chief Executive Officer at AdvanSource Biomaterials Corp (ASNB), bought 5,000 shares at $0.04 ($200) on 2012-12-10, disclosed to the SEC on 2012-12-12.
Open-market purchase of $200 ASNB by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ASNB | BUY | 2015-12-01 | $2K | — | Filing → |
| ASNB | BUY | 2015-08-24 | $650 | — | Filing → |
| ASNB | BUY | 2015-08-21 | $325 | — | Filing → |